Addus Homecare Co. (NASDAQ:ADUS) has been given an average recommendation of “Buy” by the twelve brokerages that are currently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $84.00.
ADUS has been the topic of several analyst reports. Oppenheimer raised their price objective on Addus Homecare from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. BidaskClub upgraded Addus Homecare from a “buy” rating to a “strong-buy” rating in a report on Wednesday. William Blair restated an “outperform” rating on shares of Addus Homecare in a report on Friday, August 9th. Raymond James set a $92.00 price objective on Addus Homecare and gave the stock an “outperform” rating in a report on Wednesday, August 7th. Finally, Zacks Investment Research cut Addus Homecare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 13th.
Shares of ADUS stock traded up $1.73 during mid-day trading on Thursday, hitting $88.43. 372,700 shares of the company’s stock were exchanged, compared to its average volume of 104,728. Addus Homecare has a fifty-two week low of $57.94 and a fifty-two week high of $92.91. The stock has a 50-day simple moving average of $79.13 and a two-hundred day simple moving average of $70.23. The company has a quick ratio of 2.87, a current ratio of 2.84 and a debt-to-equity ratio of 0.17. The stock has a market cap of $1.15 billion, a price-to-earnings ratio of 48.17, a PEG ratio of 2.78 and a beta of -0.10.
In related news, insider W Bradley Bickham sold 15,000 shares of the stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $80.67, for a total value of $1,210,050.00. Following the transaction, the insider now directly owns 38,311 shares of the company’s stock, valued at approximately $3,090,548.37. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Mark L. First sold 440,000 shares of the stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $74.08, for a total value of $32,595,200.00. Following the completion of the transaction, the director now directly owns 19,151 shares in the company, valued at $1,418,706.08. The disclosure for this sale can be found here. Company insiders own 20.10% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of ADUS. Marshall Wace North America L.P. purchased a new position in shares of Addus Homecare in the 1st quarter worth $34,000. Bank of Montreal Can raised its position in shares of Addus Homecare by 58.9% in the 1st quarter. Bank of Montreal Can now owns 545 shares of the company’s stock worth $35,000 after buying an additional 202 shares during the period. C M Bidwell & Associates Ltd. purchased a new position in shares of Addus Homecare in the 2nd quarter worth $40,000. Ladenburg Thalmann Financial Services Inc. raised its position in shares of Addus Homecare by 31.3% in the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 546 shares of the company’s stock worth $41,000 after buying an additional 130 shares during the period. Finally, South Dakota Investment Council purchased a new position in shares of Addus Homecare in the 1st quarter worth $83,000. 97.81% of the stock is currently owned by institutional investors and hedge funds.
Addus Homecare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Featured Story: Why do corrections happen?
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.